Twist Bioscience Corp Insider Trading for November 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Twist Bioscience Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Twist Bioscience Corp for November 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 21 2018 | TWST | Twist Bioscience C ... | Weiss Patrick | SVP, R&D GM Data St ... | Option Exercise | A | 26.66 | 118,439 | 3,157,584 | 118,439 | |
| Nov 21 2018 | TWST | Twist Bioscience C ... | Weiss Patrick | SVP, R&D GM Data St ... | Grant | A | 0.00 | 50,760 | 0 | 105,287 | 54.5 K to 105.3 K (+93.09 %) |
| Nov 21 2018 | TWST | Twist Bioscience C ... | THORBURN JAMES M | Chief Financial Off ... | Option Exercise | A | 26.66 | 91,004 | 2,426,167 | 91,004 | |
| Nov 21 2018 | TWST | Twist Bioscience C ... | THORBURN JAMES M | Chief Financial Off ... | Grant | A | 0.00 | 39,002 | 0 | 39,002 | 0 to 39 K |
| Nov 21 2018 | TWST | Twist Bioscience C ... | Peck Bill | Chief Technology Of ... | Option Exercise | A | 26.66 | 35,004 | 933,207 | 35,004 | |
| Nov 21 2018 | TWST | Twist Bioscience C ... | Peck Bill | Chief Technology Of ... | Grant | A | 0.00 | 15,002 | 0 | 723,332 | 708.3 K to 723.3 K (+2.12 %) |
| Nov 21 2018 | TWST | Twist Bioscience C ... | Leproust Emily M. | President & CEO | Option Exercise | A | 26.66 | 266,539 | 7,105,930 | 266,539 | |
| Nov 21 2018 | TWST | Twist Bioscience C ... | Leproust Emily M. | President & CEO | Grant | A | 0.00 | 114,231 | 0 | 822,561 | 708.3 K to 822.6 K (+16.13 %) |
| Nov 21 2018 | TWST | Twist Bioscience C ... | Green Paula | VP of Human Resourc ... | Option Exercise | A | 26.66 | 35,004 | 933,207 | 35,004 | |
| Nov 21 2018 | TWST | Twist Bioscience C ... | Green Paula | VP of Human Resourc ... | Grant | A | 0.00 | 15,003 | 0 | 15,003 | 0 to 15 K |
| Nov 21 2018 | TWST | Twist Bioscience C ... | Finn Patrick John | SVP, Commercial Ope ... | Option Exercise | A | 26.66 | 91,004 | 2,426,167 | 91,004 | |
| Nov 21 2018 | TWST | Twist Bioscience C ... | Finn Patrick John | SVP, Commercial Ope ... | Grant | A | 0.00 | 39,002 | 0 | 39,002 | 0 to 39 K |
| Nov 21 2018 | TWST | Twist Bioscience C ... | Daniels Mark | SVP, Chief Legal Of ... | Option Exercise | A | 26.66 | 70,000 | 1,866,200 | 70,000 | |
| Nov 21 2018 | TWST | Twist Bioscience C ... | Daniels Mark | SVP, Chief Legal Of ... | Grant | A | 0.00 | 30,000 | 0 | 51,355 | 21.4 K to 51.4 K (+140.48 %) |
| Nov 21 2018 | TWST | Twist Bioscience C ... | Banyai William | Chief Operating Off ... | Option Exercise | A | 26.66 | 91,004 | 2,426,167 | 91,004 | |
| Nov 21 2018 | TWST | Twist Bioscience C ... | Banyai William | Chief Operating Off ... | Grant | A | 0.00 | 39,002 | 0 | 747,332 | 708.3 K to 747.3 K (+5.51 %) |
| Nov 06 2018 | TWST | Twist Bioscience C ... | Ever Alpha Fund L.P. | 10% Owner | Option Exercise | C | 0.00 | 3,294,961 | 0 | 0 | |
| Nov 06 2018 | TWST | Twist Bioscience C ... | Ever Alpha Fund L.P. | 10% Owner | Buy | C | 0.00 | 3,294,961 | 0 | 3,294,961 | 0 to 3.3 M |
| Nov 06 2018 | TWST | Twist Bioscience C ... | RAGUSA ROBERT P | Director | Option Exercise | C | 0.00 | 157,215 | 0 | 0 | |
| Nov 06 2018 | TWST | Twist Bioscience C ... | RAGUSA ROBERT P | Director | Option Exercise | C | 0.00 | 673,378 | 0 | 0 | |
| Nov 06 2018 | TWST | Twist Bioscience C ... | RAGUSA ROBERT P | Director | Option Exercise | C | 0.00 | 329,305 | 0 | 0 | |
| Nov 06 2018 | TWST | Twist Bioscience C ... | RAGUSA ROBERT P | Director | Option Exercise | C | 0.00 | 542,203 | 0 | 0 | |
| Nov 06 2018 | TWST | Twist Bioscience C ... | RAGUSA ROBERT P | Director | Buy | C | 0.00 | 157,215 | 0 | 1,702,101 | 1.5 M to 1.7 M (+10.18 %) |
| Nov 06 2018 | TWST | Twist Bioscience C ... | RAGUSA ROBERT P | Director | Buy | C | 0.00 | 673,378 | 0 | 1,544,886 | 871.5 K to 1.5 M (+77.27 %) |
| Nov 06 2018 | TWST | Twist Bioscience C ... | RAGUSA ROBERT P | Director | Buy | C | 0.00 | 329,305 | 0 | 871,508 | 542.2 K to 871.5 K (+60.73 %) |
| Nov 06 2018 | TWST | Twist Bioscience C ... | RAGUSA ROBERT P | Director | Buy | C | 0.00 | 542,203 | 0 | 542,203 | 0 to 542.2 K |
| Nov 06 2018 | TWST | Twist Bioscience C ... | CRAVES FRED B | Director | Option Exercise | C | 0.00 | 8,603 | 0 | 0 | |
| Nov 06 2018 | TWST | Twist Bioscience C ... | CRAVES FRED B | Director | Option Exercise | C | 0.00 | 7,158 | 0 | 0 | |
| Nov 06 2018 | TWST | Twist Bioscience C ... | CRAVES FRED B | Director | Option Exercise | C | 0.00 | 51,010 | 0 | 0 | |
| Nov 06 2018 | TWST | Twist Bioscience C ... | CRAVES FRED B | Director | Buy | C | 0.00 | 8,603 | 0 | 66,771 | 58.2 K to 66.8 K (+14.79 %) |
| Nov 06 2018 | TWST | Twist Bioscience C ... | CRAVES FRED B | Director | Buy | C | 0.00 | 7,158 | 0 | 58,168 | 51 K to 58.2 K (+14.03 %) |
| Nov 06 2018 | TWST | Twist Bioscience C ... | CRAVES FRED B | Director | Buy | C | 0.00 | 51,010 | 0 | 51,010 | 0 to 51 K |
| Nov 06 2018 | TWST | Twist Bioscience C ... | CRANDELL KEITH | Director | Option Exercise | C | 0.00 | 894,146 | 0 | 0 | |
| Nov 06 2018 | TWST | Twist Bioscience C ... | CRANDELL KEITH | Director | Option Exercise | C | 0.00 | 224,726 | 0 | 0 | |
| Nov 06 2018 | TWST | Twist Bioscience C ... | CRANDELL KEITH | Director | Option Exercise | C | 0.00 | 266,776 | 0 | 0 | |
| Nov 06 2018 | TWST | Twist Bioscience C ... | CRANDELL KEITH | Director | Option Exercise | C | 0.00 | 718,275 | 0 | 0 | |
| Nov 06 2018 | TWST | Twist Bioscience C ... | CRANDELL KEITH | Director | Option Exercise | C | 0.00 | 1,182,645 | 0 | 0 | |
| Nov 06 2018 | TWST | Twist Bioscience C ... | CRANDELL KEITH | Director | Buy | P | 14.00 | 60,000 | 840,000 | 954,146 | 894.1 K to 954.1 K (+6.71 %) |
| Nov 06 2018 | TWST | Twist Bioscience C ... | CRANDELL KEITH | Director | Buy | C | 0.00 | 894,146 | 0 | 894,146 | 0 to 894.1 K |
| Nov 06 2018 | TWST | Twist Bioscience C ... | CRANDELL KEITH | Director | Buy | P | 14.00 | 15,000 | 210,000 | 2,407,422 | 2.4 M to 2.4 M (+0.63 %) |
| Nov 06 2018 | TWST | Twist Bioscience C ... | CRANDELL KEITH | Director | Buy | C | 0.00 | 224,726 | 0 | 2,392,422 | 2.2 M to 2.4 M (+10.37 %) |
| Nov 06 2018 | TWST | Twist Bioscience C ... | CRANDELL KEITH | Director | Buy | C | 0.00 | 266,776 | 0 | 2,167,696 | 1.9 M to 2.2 M (+14.03 %) |
| Nov 06 2018 | TWST | Twist Bioscience C ... | CRANDELL KEITH | Director | Buy | C | 0.00 | 718,275 | 0 | 1,900,920 | 1.2 M to 1.9 M (+60.73 %) |
| Nov 06 2018 | TWST | Twist Bioscience C ... | CRANDELL KEITH | Director | Buy | C | 0.00 | 1,182,645 | 0 | 1,182,645 | 0 to 1.2 M |
| Nov 06 2018 | TWST | Twist Bioscience C ... | ARCH Venture Partners VIII, LL ... | 10% Owner | Option Exercise | C | 0.00 | 894,146 | 0 | 0 | |
| Nov 06 2018 | TWST | Twist Bioscience C ... | ARCH Venture Partners VIII, LL ... | 10% Owner | Option Exercise | C | 0.00 | 224,726 | 0 | 0 | |
| Nov 06 2018 | TWST | Twist Bioscience C ... | ARCH Venture Partners VIII, LL ... | 10% Owner | Option Exercise | C | 0.00 | 266,776 | 0 | 0 | |
| Nov 06 2018 | TWST | Twist Bioscience C ... | ARCH Venture Partners VIII, LL ... | 10% Owner | Option Exercise | C | 0.00 | 718,275 | 0 | 0 | |
| Nov 06 2018 | TWST | Twist Bioscience C ... | ARCH Venture Partners VIII, LL ... | 10% Owner | Option Exercise | C | 0.00 | 1,182,645 | 0 | 0 | |
| Nov 06 2018 | TWST | Twist Bioscience C ... | ARCH Venture Partners VIII, LL ... | 10% Owner | Buy | P | 14.00 | 60,000 | 840,000 | 954,146 | 894.1 K to 954.1 K (+6.71 %) |
| Nov 06 2018 | TWST | Twist Bioscience C ... | ARCH Venture Partners VIII, LL ... | 10% Owner | Buy | C | 0.00 | 894,146 | 0 | 894,146 | 0 to 894.1 K |
| Nov 06 2018 | TWST | Twist Bioscience C ... | ARCH Venture Partners VIII, LL ... | 10% Owner | Buy | P | 14.00 | 15,000 | 210,000 | 2,407,422 | 2.4 M to 2.4 M (+0.63 %) |
| Nov 06 2018 | TWST | Twist Bioscience C ... | ARCH Venture Partners VIII, LL ... | 10% Owner | Buy | C | 0.00 | 224,726 | 0 | 2,392,422 | 2.2 M to 2.4 M (+10.37 %) |
| Nov 06 2018 | TWST | Twist Bioscience C ... | ARCH Venture Partners VIII, LL ... | 10% Owner | Buy | C | 0.00 | 266,776 | 0 | 2,167,696 | 1.9 M to 2.2 M (+14.03 %) |
| Nov 06 2018 | TWST | Twist Bioscience C ... | ARCH Venture Partners VIII, LL ... | 10% Owner | Buy | C | 0.00 | 718,275 | 0 | 1,900,920 | 1.2 M to 1.9 M (+60.73 %) |
| Nov 06 2018 | TWST | Twist Bioscience C ... | ARCH Venture Partners VIII, LL ... | 10% Owner | Buy | C | 0.00 | 1,182,645 | 0 | 1,182,645 | 0 to 1.2 M |
| Nov 01 2018 | TWST | Twist Bioscience C ... | JOHANNESSEN JAN | Director | Option Exercise | A | 14.00 | 42,304 | 592,256 | 42,304 |